These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28088896)

  • 1. Formulation and Optimization of Lansoprazole Pellets Using Factorial Design Prepared by Extrusion-Spheronization Technique Using Carboxymethyl Tamarind Kernel Powder.
    Muley SS; Nandgude T; Poddar S
    Recent Pat Drug Deliv Formul; 2017; 11(1):54-66. PubMed ID: 28088896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
    Karim S; Baie SH; Hay YK; Bukhari NI
    Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-emulsifying Pellets Prepared by Extrusion/Spheronization: In vitro/In vivo Evaluation.
    Rahman MA; Mujahid M; Hussain A
    Recent Pat Drug Deliv Formul; 2016; 10(3):245-252. PubMed ID: 27774911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality by Design (QbD) Approach for Development of Co-Processed Excipient Pellets (MOMLETS) By Extrusion-Spheronization Technique.
    Patel H; Patel K; Tiwari S; Pandey S; Shah S; Gohel M
    Recent Pat Drug Deliv Formul; 2016; 10(3):192-206. PubMed ID: 27396400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of extrusion aids for successful production of Kollidon
    Loka NC; Saripella KK; Pinto CA; Neau SH
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic drug delivery.
    Kaur H; Ahuja M; Kumar S; Dilbaghi N
    Int J Biol Macromol; 2012 Apr; 50(3):833-9. PubMed ID: 22138451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and Optimization of Multiparticulate Drug Delivery System Approach for High Drug Loading.
    Shah N; Mehta T; Gohel M
    AAPS PharmSciTech; 2017 Aug; 18(6):2157-2167. PubMed ID: 28039572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melt-in-Mouth Multi-particulate System for the Treatment of ADHD: A Convenient Platform for Pediatric Use.
    Patadia J; Tripathi R; Joshi A
    AAPS PharmSciTech; 2016 Aug; 17(4):878-90. PubMed ID: 26392403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A; Vetchý D; Janovská L; Krejcová K; Rabisková M
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR; Agrawal MK; Kumria R
    Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools.
    Gurram RK; Gandra S; Shastri NR
    Eur J Pharm Sci; 2016 Mar; 84():146-56. PubMed ID: 26812204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of rate-modulating pellets for the release of ibuprofen: an extrusion-spheronization process.
    Lutchman D; Dangor CM; Perumal D
    J Microencapsul; 2005 Sep; 22(6):643-59. PubMed ID: 16401580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.